← All organizations
Highest phase reached
Phase 2
First clinical trial
Dec 1, 2007Last known activity
Dec 31, 2022
Timeline
2000s
- Jan 1, 2006
Grupo Espanol Multidisciplinario del Cancer Digestivo— Founded
Drugs by trial phase (19 distinct, 17 trials)
Phase 2 (19 own, 0 via acquisition)
Indications
Recent trials (19)
- NCT05661188Lead sponsorPhase 2Dec 31, 2022
- NCT05201612Lead sponsorPhase 2Sep 30, 2022
- NCT04595266Lead sponsorPhase 2Jul 31, 2021
- NCT04293419Lead sponsorPhase 2Dec 18, 2019
- NCT03751176Lead sponsorPhase 2Nov 8, 2018
- NCT03142516Lead sponsorPhase 2Sep 1, 2017
- NCT03152565Lead sponsorPhase 1/Phase 2Sep 1, 2017
- NCT03000374Lead sponsorPhase 2Apr 30, 2017
- NCT02340949Lead sponsorPhase 2Jan 1, 2015
- NCT01389440Lead sponsorPhase 2May 1, 2011
- NCT01276379Lead sponsorPhase 2Jan 1, 2011
- NCT01276379Study chairPhase 2Jan 1, 2011
- NCT01288339Lead sponsorPhase 2Nov 1, 2010
- NCT01285778Lead sponsorPhase 2Oct 1, 2010
- NCT01067053Lead sponsorPhase 2Nov 1, 2009
Details
- Founded
- Madrid, ES Jan 1, 2006
- Last known activity
- Dec 31, 2022